Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Dosing Regimen in Hypovitaminosis D
NCT03272126Phase 3Completed
- Sponsor
- UiT The Arctic University of Norway
- Start
- Dec 2017
- Primary completion
- Apr 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of vitamin d in Vitamin D deficiency (VDD) (3 arms), sponsored by UiT The Arctic University of Norway. Primary endpoint: Change in serum hepcidin at 4 weeks. Started Dec 2017; status: completed.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT03272126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03272126.